Adjuvant therapy for breast cancer
- PMID: 10774471
- DOI: 10.1146/annurev.med.51.1.377
Adjuvant therapy for breast cancer
Abstract
Substantial progress has been made in the diagnosis and management of primary breast cancer over the past three decades. As a result, mortality related to this disease has been decreasing gradually for several years, treatment has become more effective, and side effects and complications related to treatment have decreased. In this report, we review the state of adjuvant therapy for breast cancer.
Similar articles
-
Adjuvant therapy for breast cancer.NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. NIH Consens Statement. 2000. PMID: 11512506 Review.
-
[Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].Cancer Radiother. 2004 Jun;8(3):188-96. doi: 10.1016/j.canrad.2004.01.003. Cancer Radiother. 2004. PMID: 15217586 Review. French.
-
[Reduced breast cancer mortality. Early treatment, as endocrine and cytostatic adjuvant therapy is effective].Lakartidningen. 1998 Aug 19;95(34):3494-7. Lakartidningen. 1998. PMID: 9742830 Review. Swedish. No abstract available.
-
[The use of adjuvant chemotherapy in stage II breast cancer in the last 25 years--a brief review].Harefuah. 2002 Apr;141(4):374-8, 408. Harefuah. 2002. PMID: 12017895 Review. Hebrew.
-
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.J Natl Compr Canc Netw. 2006 Mar;4 Suppl 1:S1-26. J Natl Compr Canc Netw. 2006. PMID: 16507275 Review.
Cited by
-
Axillary surgery in breast cancer patients.Clin Transl Oncol. 2007 Aug;9(8):513-20. doi: 10.1007/s12094-007-0095-3. Clin Transl Oncol. 2007. PMID: 17720654 Review.
-
Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.Breast Cancer Res. 2004;6(4):R275-83. doi: 10.1186/bcr787. Epub 2004 Apr 7. Breast Cancer Res. 2004. PMID: 15217493 Free PMC article.
-
Cellular uptake and concentrations of tamoxifen upon administration in poly(epsilon-caprolactone) nanoparticles.AAPS PharmSci. 2003;5(1):E3. doi: 10.1208/050203. AAPS PharmSci. 2003. PMID: 12713275 Free PMC article.
-
Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human breast cancer and ovarian cancer xenografts.Invest New Drugs. 2002 Aug;20(3):241-51. doi: 10.1023/a:1016297611825. Invest New Drugs. 2002. PMID: 12201487
-
COX-2 and cancer: a new approach to an old problem.Br J Pharmacol. 2001 Nov;134(6):1137-50. doi: 10.1038/sj.bjp.0704365. Br J Pharmacol. 2001. PMID: 11704632 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous